Page last updated: 2024-08-17

nad and opc-67683

nad has been researched along with opc-67683 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abrahams, KA; Bashiri, G; Batt, SM; Besra, GS; Gurcha, SS; Veerapen, N1

Other Studies

1 other study(ies) available for nad and opc-67683

ArticleYear
DprE2 is a molecular target of the anti-tubercular nitroimidazole compounds pretomanid and delamanid.
    Nature communications, 2023, 06-28, Volume: 14, Issue:1

    Topics: Alcohol Oxidoreductases; Antitubercular Agents; Cell Wall; Drug Resistance; Kinetics; Molecular Targeted Therapy; Mycobacterium tuberculosis; NAD; Nitroimidazoles; Prodrugs; Spectrophotometry

2023